NEW YORK (360Dx) – Avant Diagnostics on Wednesday said it has acquired an exclusive option to license Genetic Health Solution's patient-delivery technology platform.

Avant said it plans to use the platform to develop a personalized cancer patient management program that will combine blood biomarker monitoring and drug side effect profiles to help reduce negative drug side effects in cancer patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.